What’s New

News

May 10, 2024

Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024

London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease Week (DDW) Meeting…

Article

Mar 19, 2024

Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled oppo…

Publication

May 29, 2023

Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes

Niels Vande Casteele, Vipul Jairath, Wendy Teft.

Publication

May 29, 2023

Standardizing Scoring Conventions for Crohn’s Disease Endoscopy: An International RAND/UCLA Appropriateness Study

Brian G Feagan, Christopher Ma, Geert D’Haens, Guangyong Zou, Vipul Jairath.

Publication

May 29, 2023

Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis

Christopher Ma, Rocio Sedano, Vipul Jairath.

Publication

May 1, 2023

Advanced Combination Treatment With Biologic Agents and Novel Small Molecule Drugs for Inflammatory Bowel Disease

Brian G Feagan, Christopher Ma, Vipul Jairath.

Publication

Apr 24, 2023

Real-World multicentre observational study with Pop-PK modelling to evaluate the exposure-response relationship of vedolizumab in IBD

Brian Feagan, Niels Vande Casteele.

Publication

Apr 17, 2023

ATRC Review: IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

Alimentiv Translational Research Consortium (ATRC), Niels Vande Casteele.